Search results
May 6, 2020 · Studies to investigate the effects of the COVID-19 virus (SARS-CoV-2) on cancer mortality and survival are being conducted together with IARC’s international partners. Some of IARC’s contributions at the intersection of cancer and COVID-19 are described here. COVID-19 and Cancer Taskforce.
As the WHO Cancer Agency, IARC’s principles of engagement in the COVID-19 space have been to build actions together via a coordinated approach among networks of cancer experts and institutions worldwide. This document describes recent collaborations and introduces the COVID-19 and Cancer Initiative (IARC-C19) that recognizes national recovery
May 6, 2020 · 6 May 2020. COVID-19 – Latest IARC updates. All IARC operations are continuing during the COVID-19 pandemic, except for laboratory experiments.
May 7, 2020 · The International Agency for Research on Cancer (IARC), together with other leading organizations, has joined the global COVID-19 and Cancer Taskforce to help coordinate efforts to synthesize and rapidly disseminate data on how the coronavirus disease (COVID-19) pandemic is affecting cancer outcomes worldwide.
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical ...
Apr 14, 2020 · All IARC operations are continuing during the COVID-19 pandemic, except for laboratory experiments. Because access to the IARC headquarters buildings in Lyon is restricted, nearly all IARC personnel have been working remotely since Monday 16 March, to reduce the risk of transmission of the COVID-19 virus (SARS-CoV-2).
IARC participated in the COVID-19 and Cancer Global Taskforce and became a founding partner of the COVID-19 and Cancer Global Modelling Consortium, with a remit to co-develop tools and provide evidence to aid decision-making during and after the pandemic. IARC was able to clearly assess the negative impact that the pandemic has had; it interrupted
